<p>Categories for variables fitted with a trend: All variables are coded so that the lowest risk category is the reference category. BMI: <25, 25 to <30, 30 to <35, and 35+ kg/m<sup>2</sup> for breast cancer and <25, 25 to <30, 30 to <35, 35 to <40, and 40+ kg/m<sup>2</sup> for endometrial cancer; estrogen and progestin MHT use: never, <10 y, 10+ y; other/unknown MHT use: no, yes; MHT use: never, <10 y, 10+ y; age at first birth: <25, 25–29, and 30+ y; parity: 0, 1–2, and 3+ children for endometrial and ovarian cancer; age at menopause: <50, 50–54, 55+ y, missing; benign breast disease/biopsy: no, yes, missing; alcohol consumption: 0, <1, 1+ drinks/day.</p
Objective: To derive and validate a set of clinical risk prediction algorithm to estimate the 10-yea...
a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal ...
a<p>Adjusted for age (timescale), education, age at menopause (in postmenopausal women), use of MHT ...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
<p>Relative risk<sup>1</sup> (RR<sup>1</sup>) is stratified by study, age at diagnosis, parity, meno...
For Hispanic women, the Breast Cancer Risk Assessment Tool (BCRAT; "Gail Model") combines 1990-1996 ...
<p>Test for trend: height, <i>p</i><0.001; weight, <i>p</i><0.001; body mass index, <i>p</i><0.001. ...
The objective of the present study is to investigate key aspects of ovarian and breast cancers, ...
An improved model for risk stratification can be useful for guiding public health strategies of brea...
a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal ...
<p>Relative risk<sup>1</sup> (RR<sup>1</sup>) is stratified by study, age at diagnosis, parity, meno...
<p>The multivariate models used person-time as the underlying time metric and included the following...
<p>Women with missing information on hormone receptor status were excluded from this analysis (<i>n ...
<p>Relative risk compared to women with height <160 cm and stratified by study, age at diagnosis, pa...
a.<p>Subjects who did not have any prevalent cancer except non-melanoma skin cancer or heart disease...
Objective: To derive and validate a set of clinical risk prediction algorithm to estimate the 10-yea...
a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal ...
a<p>Adjusted for age (timescale), education, age at menopause (in postmenopausal women), use of MHT ...
Breast, endometrial, and ovarian cancers share some hormonal and epidemiologic risk factors. While s...
<p>Relative risk<sup>1</sup> (RR<sup>1</sup>) is stratified by study, age at diagnosis, parity, meno...
For Hispanic women, the Breast Cancer Risk Assessment Tool (BCRAT; "Gail Model") combines 1990-1996 ...
<p>Test for trend: height, <i>p</i><0.001; weight, <i>p</i><0.001; body mass index, <i>p</i><0.001. ...
The objective of the present study is to investigate key aspects of ovarian and breast cancers, ...
An improved model for risk stratification can be useful for guiding public health strategies of brea...
a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal ...
<p>Relative risk<sup>1</sup> (RR<sup>1</sup>) is stratified by study, age at diagnosis, parity, meno...
<p>The multivariate models used person-time as the underlying time metric and included the following...
<p>Women with missing information on hormone receptor status were excluded from this analysis (<i>n ...
<p>Relative risk compared to women with height <160 cm and stratified by study, age at diagnosis, pa...
a.<p>Subjects who did not have any prevalent cancer except non-melanoma skin cancer or heart disease...
Objective: To derive and validate a set of clinical risk prediction algorithm to estimate the 10-yea...
a<p>Adjusted for age (timescale), education, menopausal status, age at menopause (in postmenopausal ...
a<p>Adjusted for age (timescale), education, age at menopause (in postmenopausal women), use of MHT ...